TipRanks
Zymeworks Inc (ZYME)
NASDAQ:ZYME
US Market
ZYME
Zymeworks
RESEARCH TOOLSreports
Want to see ZYME full AI Analyst Report?

Zymeworks (ZYME) Stock News & Sentiment

658 Followers
Charles Zhu Reiterates Buy on Zymeworks, Keeps $34 Price Target After TBPH Acquisition Boosts Growth and Cash Flow Outlook
Premium
Ratings
Charles Zhu Reiterates Buy on Zymeworks, Keeps $34 Price Target After TBPH Acquisition Boosts Growth and Cash Flow Outlook
7d ago
ZYME
Zymeworks Closes Theravance Acquisition and CVR Financing
Premium
Company Announcements
Zymeworks Closes Theravance Acquisition and CVR Financing
12d ago
8K
ZYME
Zymeworks Gains $250 Million Milestone as Jazz Wins FDA Nod for HER2 Cancer Regimens
Premium
Company Announcements
Zymeworks Gains $250 Million Milestone as Jazz Wins FDA Nod for HER2 Cancer Regimens
1M ago
ZYME
Zymeworks Gains Second FDA Nod for Zanidatamab, Unlocking Major Milestones
Premium
Company Announcements
Zymeworks Gains Second FDA Nod for Zanidatamab, Unlocking Major Milestones
1M ago
ZYME
Zymeworks Steps Up Investor Outreach with September Conference Lineup
Premium
Company Announcements
Zymeworks Steps Up Investor Outreach with September Conference Lineup
2M ago
ZYME
Zymeworks Posts Strong Q2 Results, Highlights Growth Catalysts
Premium
Company Announcements
Zymeworks Posts Strong Q2 Results, Highlights Growth Catalysts
2M ago
8K
ZYME
Zymeworks Earns Buy Rating as Non-Dilutive Theravance Deal and Long-Duration YUPELRI Cash Flows Drive Price Target Up to $37
Premium
Ratings
Zymeworks Earns Buy Rating as Non-Dilutive Theravance Deal and Long-Duration YUPELRI Cash Flows Drive Price Target Up to $37
3M ago
ZYME
More ZYME News >

ZYME News on the Web

Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish
Zymeworks Closes Theravance Acquisition and CVR Financing
TipRanks News
Neutral
Zymeworks Inc. at Morgan Stanley Global Healthcare Conference Transcript
GuruFocus News
Neutral
Analysts Are Bullish on These Healthcare Stocks: Zymeworks (ZYME), Jazz Pharmaceuticals (JAZZ)
TipRanks News
Bullish
Zymeworks Soars as FDA Milestone Bet Heats Up
TipRanks News
Bullish
BeOne announces FDA approval for Tevimbra-based reginmen for HER2+ GEA
TipRanks News
Bullish
Truist Financial Keeps Their Buy Rating on Zymeworks (ZYME)
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Zymeworks (ZYME) and Edgewise Therapeutics (EWTX)
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
ZYME
Sector Average
Media Buzz
This Week6 articles
Weekly Average3.75 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ZYME’s Media Buzz Sentiment?
6 articles about ZYME were published this week. In an average week, 3.75 articles are published.
    What is ZYME’s weekly average amount of articles?
    In an average week, 3.75 articles about ZYME are published.
      What is ZYME’s News Sentiment?
      100% of articles about ZYME were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        BAYRYBayer
        ABTAbbott Laboratories
        INCYIncyte
        SMMTSummit Therapeutics
        CRVOCervoMed
        Showing the stocks with the most bullish news sentiment over the past week